While this study specifically focused on this phenomenon in pulmonary sarcoidosis, analogous studies are required in order to determine whether this trend holds true for HLA-DRB1*03+ patients with other inflammatory diseases. The gene discussed is HLA-DRB1; the disease is pulmonary sarcoidosis.